REGOMUNE

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Open at Saint-Cloud since : 25/10/2021
Target : Adult
Phase : Phase I/II

Trial description

Assessment of the efficacy and safety of Regorafenib and Avelumab in patients with advanced or metastatic solid tumors (ten cohorts), once the Recommanded Phase II Dose (RP2D) has been determined (phase I trial).

Url of the trial

Main investigator

SEGOLENE HESCOT

Médecin

Contact